Concepedia

Wout De Wispelaere

WD

4

Publications

103

Citations

4

H-Index

2022

Active since

Affiliations

KU Leuven(Current)

The Netherlands Cancer Institute

Oncode Institute

VIB-KU Leuven Center for Cancer Biology

Wout De Wispelaere is an author at KU Leuven specializing in medicine, drug monitoring, and autoantibodies.

Top concepts

MedicineImmunologyAutoimmunityImmunotherapyAutoantibodiesDrug MonitoringAutoimmune DiseaseRheumatic DiseasesRheumatoid Arthritis

Publications per year

2022–2024

4

Publications

4

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

Tom Van Nyen, Mélanie Planque, Lilian van Wagensveld et al. · Nature Communications · 2022 · 42 citations · Full text

Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases

Henry Ordutowski, Francesco Dal Dosso, Wout De Wispelaere et al. · Biosensors and Bioelectronics · 2022 · 33 citations · Full text

Rheumatoid Disorder, Therapeutic Drug Monitoring, Point-of-care Testing +13

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD‐1 blockade

Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts et al. · Clinical and Translational Medicine · 2024 · 16 citations · Full text

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma

Raul Maia Falcão, Georgia Kokaraki, Wout De Wispelaere et al. · Cancers · 2022 · 12 citations · Full text

Rows per page

1–4 of 4